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Middle East respiratory syndrome (MERS) cases continue 
to be reported, predominantly in Saudi Arabia and occasion-
ally other countries. Although dromedaries are the main res-
ervoir, other animal species might be susceptible to MERS 
coronavirus (MERS-CoV) infection and potentially serve as 
reservoirs. To determine whether other animals are poten-
tial reservoirs, we inoculated MERS-CoV into llamas, pigs, 
sheep, and horses and collected nasal and rectal swab 
samples at various times. The presence of MERS-CoV in 
the nose of pigs and llamas was confirmed by PCR, titration 
of infectious virus, immunohistochemistry, and in situ hy-
bridization; seroconversion was detected in animals of both 
species. Conversely, in sheep and horses, virus-specific 
antibodies did not develop and no evidence of viral replica-
tion in the upper respiratory tract was found. These results 
prove the susceptibility of llamas and pigs to MERS-CoV 
infection. Thus, the possibility of MERS-CoV circulation in 
animals other than dromedaries, such as llamas and pigs, 
is not negligible.
Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) first emerged in 2012 in Saudi Arabia 
and is currently a worldwide concern (1). As of Septem-
ber 21, 2016, the World Health Organization had confirmed 
≈1,800 MERS cases and 643 associated deaths (2). Although 
during most reported outbreaks the virus is mainly transmit-
ted by human-to-human contact, infection through contact 
with dromedary camels (Camelus dromedaries) plays a ma-
jor role in the primary cases. In the Middle East and some 
countries from East Africa where MERS is endemic, high 
prevalence of MERS-CoV–specific antibodies in drom-
edaries has been reported (3–7). Moreover, a recent surveil-
lance study in Saudi Arabia demonstrated that MERS-CoV 
strains isolated from humans were also detected in the upper 
respiratory tract of dromedaries of several geographic ori-
gins, indicating that the virus did not require mutations to 
jump between species (8). However, not all index cases can 
be explained by direct contact with dromedaries, and trans-
mission from other domestic livestock or animal species to 
humans cannot yet be ruled out. Recently, evidence that al-
pacas (Vicugna pacos) were also susceptible to MERS-CoV 
infection was provided and confirmed by field studies per-
formed in Qatar (9–11). In contrast, despite the ability of the 
virus to infect a plethora of cell lines and tissues from mam-
mals of multiple species in vitro (12), serologic surveys 
of ruminants and horses did not conclusively determine 
circulation of MERS-CoV among these domestic animals 
(6,13,14). Sampling design could explain negative results, 
and experimental infections provide, in many instances, a 
more straightforward answer to virus host susceptibility. 
This knowledge is crucial for determining risk factors with 
regard to possible globalization of the disease.
Our aim with this study was to address these critical 
research gaps and to understand the potential role that other 
animals (besides dromedaries and alpacas) could play in 
MERS-CoV dissemination. We experimentally inoculated 
MERS-CoV into llamas (Lama glama), pigs (Sus scrofa), 
horses (Equus ferus caballus), and sheep (Ovis aries). We 
based our selection of species on epidemiologic interest 
and on sequence similarities in the MERS-CoV receptor 
binding domain of dipeptidyl peptidase-4 (DPP4).
Materials and Methods
Ethics
All experiments with MERS-CoV were performed at 
Biosafety Level 3 (BSL-3) facilities of the Biocontain-
ment Unit of the Institut de Recerca i Tecnologia Agroali-
mentàries (IRTA) Centre de Recerca en Sanitat Animal 
(CReSA) in Barcelona, Spain. The study was approved by 
the Ethical and Animal Welfare Committee of IRTA and 
the Ethical Commission of Animal Experimentation of the 
Autonomous Government of Catalonia.
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Cells and MERS-CoV
Vero cells were cultured in Dulbecco modified Eagle me-
dium (DMEM; Lonza, Basel, Switzerland) supplemented 
with 1% fetal calf serum (EuroClone, Pero, Italy), 100 U/
mL penicillin, 100 mg/mL streptomycin, and 2 mmol/L 
glutamine. Passage 7 human isolate MERS-CoV stock 
(HCoV-EMC/2012) was propagated in Vero cells at 37°C 
in a CO2 incubator for 3 days. The infectious virus titer 
was determined in Vero cells and calculated by determin-
ing the dilution that caused cytopathic effect in 50% of the 
inoculated cell cultures (50% tissue culture infectious dose 
endpoint [TCID50]).
Animal Studies
All animals used in this study were obtained from France 
and Spain by private sale and housed at BSL-3 animal fa-
cilities (IRTA-CReSA, Barcelona, Spain). We obtained 
8 llamas (6–8 months of age), 8 horses (6–8 months), 14 
sheep (2–3 months), and 14 pigs (2 months). We intrana-
sally inoculated a 107 TCID50 dose in 3 mL saline solution 
into each animal (1.5 mL in each nostril) by using a mucosal 
atomization device (LMA; North-America, Inc., San Diego, 
CA, USA) and monitored the animals daily for clinical signs 
(sneezing, coughing, nasal discharge, dyspnea). Rectal tem-
peratures were recorded with a fast display digital thermom-
eter (Digi-Temp; Kruuse Veterinary Products, Langeskov, 
Denmark) until postinoculation day 10. Nasal and rectal 
swabs were obtained on postinoculation days 1, 2, 3, 4, 7, 
10, 14, and 24 in phosphate-buffered saline (PBS) (for PCR 
analysis) and DMEM (for virus isolation and titration) con-
taining antimicrobial drugs (100 U/mL penicillin and 0.1 
mg/mL streptomycin). All samples were stored at −80°C 
until tested. Serum samples were obtained before challenge 
and at postinoculation days 14 and 24 and were subsequent-
ly used to detect MERS-CoV–specific antibodies.
Virus Titration
Nasal swabs collected at different times after inoculation 
were evaluated for infectious virus by titration in Vero 
cells. We prepared 10-fold dilutions, starting with a dilu-
tion of 1:10, and transferred the dilutions to Vero cells. 
Plates were monitored daily under a light microscope, and 
wells were evaluated for cytopathic effect. The final de-
termination was conducted on postinoculation day 5. The 
amount of infectious virus in swab samples was calculated 
by determining the TCID50.
Pathology Studies
On postinoculation day 2, we euthanized 4 pigs and 4 sheep 
with an overdose of pentobarbital followed by exsanguina-
tion; using the same procedure, on postinoculation day 4, 
we euthanized 4 animals of each species (including llamas 
and horses) and on postinoculation day 24, the remaining 
animals. We performed complete necropsies and collected 
respiratory tissues (frontal, medial, and caudal turbinates; 
proximal, medial and distal trachea; large and small bron-
chi; and right cranial, mediodorsal, and caudal lung paren-
chyma) for virologic, histopathologic, immunohistochemi-
cal (IHC), and in situ hybridization (ISH) examination.
Tissues for pathology studies were fixed by immersion 
in 10% neutral-buffered formalin, embedded in paraffin, 
and sectioned at 3 µm for slides. Sequential slides were 
either stained with hematoxylin and eosin or used to detect 
the DPP4 receptor and MERS-CoV antigen by IHC and 
viral genome by ISH (15,16). In brief, we performed DPP4 
IHC staining by using 5 µg/mL of polyclonal goat IgG anti-
human DPP4 antibody (R&D Systems, Abingdon, UK) and 
peroxidase-labeled rabbit anti-goat IgG (1:200; DAKO; 
Agilent Technologies Company, Santa Clara, CA, USA) 
as a secondary antibody. To detect MERS-CoV antigen, 
we used a monoclonal antibody to the nucleocapsid protein 
(SinoBiological Inc., Beijing, China) as described (16). We 
performed ISH according to the manufacturer’s instruc-
tions by using probes targeting the nucleocapsid gene of 
MERS-CoV (Advanced Cell Diagnostics, Hayward, CA, 
USA). ISH staining was detected by using the Fast Red 
substrate as previously reported (17). For detection of mu-
cous substances, we stained selected slides (from animals 
euthanized on postinoculation day 24) with periodic acid–
Schiff (PAS) according to standard methods.
Viral RNA Detection by Reverse Transcription PCR
We collected tissues (0.2–0.5 g) for viral RNA quantification 
and placed them in cryotubes containing beads and 500 µL 
DMEM supplemented with 100 U/mL penicillin, 100 mg/
mL streptomycin, and 2 mmol/L glutamine. In brief, samples 
were homogenized at 30 Hz for 2 min by using a TissueLys-
er II (QIAGEN, Hilden, Germany) and stored at −70°C until 
use. We extracted viral RNA from nasal swabs, rectal swabs, 
and tissue homogenates by using a NucleoSpin RNA virus 
kit (Macherey-Nagel, Düren, Germany) according to the 
manufacturer’s instructions. The RNA extracts were tested 
by UpE PCR (18). We conducted reverse transcription quan-
titative PCR (RT-qPCR) by using AgPath-ID One-Step RT-
PCR reagents (Applied Biosystems, Foster City, CA, USA) 
and performed amplification by using a 7500 Fast Real-Time 
PCR System (Applied Biosystems) programmed as follows: 
5 min at 50°C, 20 s at 95°C, and 45 cycles of 3 s at 95°C and 
30 s at 60°C. We considered samples with a cycle threshold 
<40 positive for MERS-CoV RNA.
MERS-CoV S1 ELISA
We determined specific S1 antibodies in serum samples 
from postinoculation days 0, 14, and 24 by a MERS-CoV S1 
ELISA as previously described (16), with some modifica-
tions. In brief, 96-well high-binding plates (Sigma-Aldrich, 
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St. Louis, MO, USA) were coated with 100 µL of S1 pro-
tein at 1 µg/mL in PBS overnight at 4°C. After blocking 
with 1% bovine serum albumin/PBS/0.5% Tween20 for 1 
h at 37°C, individual serum samples were added at 1:100, 
followed by 1 h incubation at 37°C. Plates were washed 4 
times with PBS, and the species-specific secondary anti-
body was added. We used the following conjugates: anti-
llama IgG:horseradish peroxidase (HRP) (diluted 1:60,000; 
no. A160–100P, Bethyl Laboratories, Montgomery, TX, 
USA); anti-pig IgG:HRP (diluted 1:20,000; no. A5670, 
Sigma-Aldrich); anti-horse IgG(T):HRP (diluted 1: 10,000; 
no. AAI38P, Bio-Rad, Hercules, CA, USA); and anti-sheep 
IgG:HRP (diluted 1:10,000; no. 5184–2504, Bio-Rad). After 
1 h of incubation at 37°C, wells were washed 4 times with 
PBS, and TMB (3,3′,5,5′-tetramethylbenzidine) substrate 
solution was added and allowed to develop for 8–10 min at 
room temperature, protected from light. We measured opti-
cal density at 450 nm.
MERS-CoV Neutralization Assay
We also tested serum samples collected on postinocula-
tion days 0, 14, and 24 by a specific virus neutralization 
assay. First, the samples were inactivated at 56°C for 
30 min. Following a previous protocol (16), we mixed 
400 PFU of MERS-CoV (HCoV-EMC/2012) with serial 
2-fold dilutions of heat-inactivated serum, incubated the 
mixture 1 h at 37°C, and inoculated it onto Huh7 cells. 
The presence of viral antigen was assessed 8 h after in-
oculation. Cells were fixed with formaldehyde and stained 
by using rabbit anti–MERS-CoV antibodies and fluores-
cein isothiocyanate–conjugated swine anti-rabbit immu-
noglobulins as secondary antibodies. We calculated 90% 
plaque-reduction neutralization test values for the MERS-
CoV neutralization assay.
Results
Clinical Signs
After challenge, 3 of 8 llamas showed clinical signs (mod-
erate mucus secretion in 1 nostril) at postinoculation days 
4–18 (online Technical Appendix Figure 1, panel A, http://
wwwnc.cdc.gov/EID/article/23/2/16-1239-Techapp1.pdf). 
Soon after inoculation, mild excretion of white mucus from 
the nose was noted for 3 pigs. Minimal mucus excretion in 
the nose was noted at variable times (postinoculation days 
2–16) for 3 horses. We did not detect nasal discharge in any 
of the sheep during the experiment. No animal of any spe-
cies showed a significant increase in body temperature after 
MERS-CoV inoculation (online Technical Appendix Figure 
1, panel B).
MERS-CoV RNA and Infectious Virus in Nasal Swab 
Samples and Viral RNA in Respiratory Tissues
Pigs and llamas excreted virus in the nose, as evidenced 
by RT-qPCR of nasal swab samples from postinoculation 
days 1–10; in 1 llama, viral RNA was detected until post-
inoculation day 15 (Figure 1, panel A). At postinoculation 
day 7, the amount of MERS-CoV RNA was still high in all 
234 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No. 2, February 2017
Figure 1. Viral shedding of llamas and pigs after experimental inoculation with MERS-CoV. A) Viral RNA and B) infectious MERS-
CoV from nasal swab samples collected from llamas (top) and pigs (bottom) at different times after challenge. Each bar represents 
an individual animal. Dashed lines depict the detection limit of the assays. Ct, cycle threshold; MERS-CoV, Middle East respiratory 
syndrome coronavirus; TCID50, 50% tissue culture infective dose.
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llamas, but a decrease in RNA level was noted at postin-
oculation day 10. In pigs, high levels of MERS-CoV RNA 
were demonstrated until postinoculation day 4 and start-
ed decreasing at postinoculation day 7; only 1 animal re-
mained positive at postinoculation day 10 (Figure 1, panel 
A). We subsequently tested positive nasal swab samples 
for the presence of infectious virus. During the experiment, 
7 of 8 llamas and 7 of 14 pigs excreted infectious virus 
during at least 1 day from postinoculation day 2 on. We 
detected infectious virus until postinoculation day 4 in pigs 
and postinoculation day 7 in llamas (Figure 1, panel B). 
Relatively low levels of viral RNA were detected only un-
til postinoculation day 2 in 5 of 8 inoculated horses and 
only at postinoculation day 1 in 7 of 14 sheep, suggesting 
the presence of residual inoculum in these animals (data 
not shown). We did not detect virus in rectal swab samples 
from any animal.
To determine the presence of viral RNA in tissues, we 
euthanized representative numbers of animals on postin-
oculation days 2 (pigs), 4 (llamas and pigs), and 24 (lla-
mas and pigs) and tested tissue homogenates by RT-qPCR. 
Early after infection, virus RNA transcripts were detected 
mainly in the nose, trachea, and small and large bronchi of 
llamas and pigs (Figure 2). At postinoculation day 24, viral 
RNA was detected only in some tissues (caudal nose and 
trachea) in 2 llamas (Figure 2).
Pathology, IHC, and ISH
We observed no substantial macroscopic changes attribut-
able to MERS-CoV infection in any animals. All horses 
exhibited purulent inflammation of the guttural pouch (em-
pyema), which was most likely of bacterial origin.
At postinoculation day 4, IHC and ISH demonstrated 
virus antigen and nucleic acid in a few nasal respiratory 
epithelial cells in 3 of 4 llamas and in 2 of 4 pigs (Figure 
3). At postinoculation day 2, occasional alveolar epithelial 
cells were positive for antigen and nucleic acid in 1 of 4 
pigs. Also at postinoculation day 2, occasional bronchio-
lar cells from 1 of 4 sheep were positive for MERS-CoV 
(online Technical Appendix Figure 2). MERS-CoV antigen 
was absent in the rest of the respiratory tissues of animals 
of all species collected on any of the days. Associated with 
the presence of virus antigen and nucleic acid, llamas and 
pigs demonstrated a mild to moderate rhinitis characterized 
by mild to moderate epithelial necrosis with infiltration of 
variable numbers of neutrophils in the epithelium (exocy-
tosis) and in the lumen and mild to severe infiltration of the 
lamina propria with variable numbers of macrophages, lym-
phocytes, neutrophils, and plasma cells and multifocal mild 
edema. We also observed mild to moderate multifocal epi-
thelial hypertrophy consistent with regeneration (Figure 2). 
We observed no other relevant microscopic lesions in hors-
es (besides the evidence of purulent empyema) and sheep.
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Figure 2. MERS-CoV viral RNA in respiratory tissues of llamas (A) and pigs (B). Viral RNA was determined in tissue homogenates at 
postinoculation days 4 and 24. Error bars indicate SDs when results were positive in >1 animal. Dashed lines depict the detection limit of 
the assays (Ct ≤40). Ct, cycle threshold; MERS-CoV, Middle East respiratory syndrome coronavirus; PI, postinoculation.
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DPP4 Receptor Distribution and Presence of  
Mucosubstances in Respiratory Tissues 
DPP4 IHC staining of upper and lower respiratory tract tis-
sues collected on postinoculation day 24 found DPP4 ex-
pression on the respiratory epithelium of the nose of llamas, 
pigs, and horses but only to a very limited extent on that of 
sheep (Figure 4, panel A). We also detected DPP4 expres-
sion in the lower respiratory tract (but mainly restricted to 
tracheal and bronchial epithelia) of horses, llamas, and pigs 
(Figure 4, panel B). PAS staining demonstrated the pres-
ence of mucosubstances in the nose of llamas, pigs, horses, 
and sheep, with a relatively higher number of mucous (gob-
let) cells in the lining epithelium of sheep and horses. In the 
horses only, there was also a layer of mucus covering lining 
epithelium with a multifocal distribution.
Specific Humoral Immune Response
ELISA results showed antibodies against the S1 protein in 
all llamas and pigs from postinoculation day 14 on, although 
the response in pigs was weaker than that in llamas (Figure 
5, panel A). We confirmed the specificity of the response 
by virus neutralization assay (Figure 5, panel B). In all 
llamas, serum neutralizing MERS-CoV-specific antibody 
titers (1:80 to 1:320) were detected at postinoculation days 
14 and 24. In addition, 14 days after challenge, in 5 of 6 
pigs, MERS-CoV neutralizing antibodies were detected 
(1:80 to 1:160). However, 10 days later, these virus neutral-
izing antibodies decreased (1:20 to 1:40) (Figure 5, panel 
B). We detected no MERS-CoV–specific antibodies in se-
rum of sheep and horses.
Discussion
Our study results indicate that pigs and llamas are suscepti-
ble to MERS-CoV infection. These animals shed infectious 
virus until postinoculation days 4 (pigs) and 7 (llamas), al-
though titers were lower among pigs. In pigs and llamas, 
we detected virus predominantly in the nasal respiratory 
epithelium by IHC, ISH, or both, similar to what has been 
documented in dromedary camels (16) and alpacas (9). Ac-
cordingly, we mainly detected viral RNA, as assessed by 
RT-qPCR, in the nose, trachea, and bronchi of those ani-
mals. We also detected viral RNA in lung tissue from 2 of 
4 pigs euthanized at postinoculation day 2. Virus shedding 
in dromedary camels and alpacas for longer periods, up to 
14 days after experimental inoculation, has been reported 
(9,16,19). Of note, the level of MERS-CoV excreted in the 
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Figure 3. Histology and expression of viral antigen (IHC) and viral RNA (ISH) at postinoculation day 4 in the nasal respiratory epithelium 
of sheep, pigs, llamas, and horses inoculated with MERS-CoV. A mild to severe rhinitis with epithelial necrosis and hypertrophy and 
inflammation of the epithelium and lamina propria was observed in the nasal respiratory tissue of pigs and llamas. Associated with these 
was presence of virus antigen (IHC) and RNA (ISH). No substantial lesions, virus antigen, or virus RNA were detected in the nasal 
respiratory tissues of sheep and horses (HE, IHC, ISH). Original magnification ×200 for all images. HE, hematoxylin and eosin; IHC, 
immunohistochemistry; ISH, in situ hybridization; MERS-CoV, Middle East respiratory syndrome coronavirus.
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Figure 4. Presence of MERS-CoV receptor DPP4 (IHC) and of mucosubstances (PAS) in upper and lower respiratory tract tissues from 
sheep, pigs, llamas, and horses. A) In the nose, DPP4 (red cytoplasmic or membrane staining) was present on the lining epithelium 
of pigs, llamas, and horses but not sheep. PAS staining (magenta) demonstrated more mucous cells in the lining epithelium of sheep 
and horses and a layer of mucus on the lining epithelium of the horses. B) DPP4 (red cytoplasmic or membrane staining) was present 
on the lining epithelium of the trachea, bronchus/bronchioles, and alveoli in the pigs, llamas and horses but not in the sheep. Original 
magnification ×400 for all images. DPP4, dipeptidyl peptidase-4; IHC, immunohistochemistry; MERS-CoV, Middle East respiratory 
syndrome coronavirus; PAS, periodic acid–Schiff; term., terminal. 
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nose of dromedaries seems to be much higher (16,19) than 
that of other animal species described so far, suggesting 
a more prominent role of dromedaries in transmission of 
MERS-CoV to humans.
Differences in virus susceptibility and pathogenicity 
between animals of different species could be explained 
by a distinct tissue distribution of DPP4, the MERS-CoV 
receptor. In our study, llamas and pigs displayed a simi-
lar DPP4 distribution in the respiratory tract, comparable 
with that of dromedary camels (15). In contrast, DPP4 was 
barely detected in the respiratory tract of sheep, probably 
accounting for the lack of infection reported here. These 
results are in concordance with those reported by Adney 
et al., that MERS-CoV experimentally inoculated sheep 
showed no clinical disease and that only small amounts 
of virus were detected in nasal swab samples (20). Differ-
ences in susceptibility to MERS-CoV infection and level 
of virus excretion might also result from host factors as-
sociated with innate immunity. Surprisingly, horses were 
not susceptible to MERS-CoV despite high expression and 
wide distribution of the virus receptor along the respira-
tory tract. Moreover, the receptor binding domain, and in 
particular key amino acids on the docking site, are identical 
in horses and humans (21). Although human, camel, and 
horse DPP4 served as potent and nearly equally effective 
MERS virus receptors (22), horses were not productively 
infected by the strain of MERS-CoV used in this study. De-
tection of low levels of viral RNA in nasal swab samples 
until postinoculation day 2 can be attributed to residual in-
oculum. Similarly, a recent study with horses also showed 
low levels of MERS-CoV excretion and no virus neutral-
izing antibodies (20). 
These results highlight that other mechanisms, such 
as epithelial cell permissibility or strong innate immune 
responses, may influence the establishment of infection. 
In that respect, PAS staining revealed differences in the 
number of goblet cells in the lining epithelium and mucus 
covering epithelial surfaces, which may have impeded the 
binding of the virus to the respiratory epithelium of horses. 
Also, virus tends to bind more to ciliated or nonciliated 
non–mucus-producing cells and, in proportion, these cells 
may be fewer in horses than in llamas and pigs. Howev-
er, it is possible that the guttural pouch empyema, which 
most likely was of bacterial origin (probably Streptococ-
cus spp.), may have influenced mucus production in the 
horses. Although these observations are in line with those 
from studies in the field indicating the absence of antibod-
ies to MERS-CoV in equids (14), this aspect should be 
studied further.
Epidemiologic studies have provided evidence of en-
demic MERS-CoV infection among dromedaries in the 
Greater Horn of Africa as far back as 1983 (23,24) and in 
Saudi Arabia as far back as 1992–1993 (25). To implement 
optimal serologic surveillance in countries where MERS is 
and is not endemic, identifying which animal species might 
be potential reservoirs for MERS-CoV, besides dromedar-
ies, is crucial. The finding that pigs can be infected with 
MERS-CoV suggests that other members of the family Sui-
dae could be susceptible to the virus, such as common wart-
hogs (Phacochoerus africanus), bushpigs (Potamochoerus 
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Figure 5. Antibody responses 
after experimental inoculation 
of MERS-CoV into llamas 
and pigs. A) MERS-CoV S1 
antibody responses were 
analyzed in serum from all 
animals at postinoculation days 
0, 14, and 24. An ELISA with 
recombinant MERS-CoV S1 
protein was used, and results 
are represented individually. 
B) Individual MERS-CoV 
neutralization titers from llamas 
and pigs as determined from 
serum. Dashed lines depict 
the detection limit of the 
assays. MERS-CoV, Middle 
East respiratory syndrome 
coronavirus; OD, optical density; 
PRNT90, 90% plaque reduction 
neutralization test.
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larvatus), and wild boars (Sus scrofa scrofa). Indeed, these 
animals are commonly found in the Greater Horn of Africa 
or the Middle East, sharing territories and water sources 
with dromedaries. Thus, members of the family Suidae 
might merit inclusion in MERS surveillance programs. 
Further studies need to be done to investigate MERS-CoV 
transmission within and among species to provide a better 
understanding of the role of potential reservoirs during an 
outbreak. Moreover, studies comparing the innate immuni-
ty of horses with susceptibility of other animal species (i.e., 
dromedary camels, alpacas, llamas, or pigs) are needed.
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